Looks like you’re on the UK site. Choose another location to see content specific to your location

Services company Ethos acquired by Precision Medicine Group

24th July 2018

Precision Medicine Group has acquired Ethos to enhance its complex data interpretation abilities. ETHOS Health Communications has more than 120 employees and specialises in the interpretation and communication of medical science. In its 15 year history, it has offered medical affairs and marketing-based scientific knowledge to stakeholders within biopharmaceutical and biotechnology firms.

Mark Clein, Precision Medicine Group’s CEO, said: “As medical innovations become increasingly complex, the demand for clarity, insight and compelling communications becomes a fundamental success factor for drug developers seeking to convey the medical and economic benefits of their products. With ETHOS, these developers can better translate their science to the multiple constituents that prescribe, utilise, regulate and insure their products. With this addition, Precision has enhanced our proficiency in demonstrating the clinical value of medical innovations throughout the entire development and commercial life cycle.”

Anita O’Connor, ETHOS co-founder and president, said: “We are very happy to be joining the Precision family and partnering with other Precision teams to provide the highest level of expertise to help our clients achieve their objectives and to bring the best science and medicine to patients and healthcare professionals. Our company culture and mission align very closely with Precision’s, and we are very excited about the added value we can now offer both existing and new clients.”

We currently have 14 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.